Gritstone bio Inc.

11/29/2021 | Press release | Distributed by Public on 11/29/2021 06:09

The Omicron Variant of SARS-CoV-2 has Minimal Impact on the T Cell Epitopes (Targets) Contained within Gritstone’s Self-Amplifying mRNA COVID-19 Vaccines